Copyright
©The Author(s) 2021.
World J Gastroenterol. Oct 21, 2021; 27(39): 6689-6700
Published online Oct 21, 2021. doi: 10.3748/wjg.v27.i39.6689
Published online Oct 21, 2021. doi: 10.3748/wjg.v27.i39.6689
Table 3 Factors associated with survival
Hazard ratio1 (95%CI) | |
Sex | |
Male | 1 |
Female | 1.18 (0.89-1.58) |
Age (yr) | 1.06 (1.04-1.07) |
Colorectal location | |
Distal to splenic | 1 |
Proximal to splenic | 0.84 (0.62-1.13) |
Cohort | |
Pre-implantation | 1 |
Post-implantation | 1.12 (0.83-1.51) |
TNM | |
I | 1 |
II | 2.17 (1.07-4.40) |
III | 3.07 (1.56-6.08) |
IV | 19.22 (9.86-37.44) |
Unknown | 9.24 (4.27-19.99) |
Initial consultation | |
Primary healthcare | 1 |
Secondary healthcare | 2.93 (1.01-8.55) |
Emergency department | 2.06 (0.67-6.34) |
Hospitalization | |
Yes | 1.67 (1.17-2.38) |
No | 1 |
Colonoscopy request | |
Primary healthcare | 1.79 (0.96-3.35) |
Secondary healthcare | 1.54 (0.92-2.58) |
After referral from Primary Healthcare | 0.74 (0.25-2.21) |
Direct request | 1 |
No colonoscopy | |
Rural/Urban | |
Rural | 1 |
Urban | 1.44 (1.06-1.98) |
Diagnostic delay (d) | 1.001 (1.00-1.002) |
- Citation: Cubiella J, Lorenzo M, Baiocchi F, Tejido C, Conde A, Sande-Meijide M, Castro M. Impact of a colorectal cancer screening program implantation on delays and prognosis of non-screening detected colorectal cancer. World J Gastroenterol 2021; 27(39): 6689-6700
- URL: https://www.wjgnet.com/1007-9327/full/v27/i39/6689.htm
- DOI: https://dx.doi.org/10.3748/wjg.v27.i39.6689